|
US7144880B2
(en)
*
|
1999-04-30 |
2006-12-05 |
Regents Of The University Of Michigan |
Compositions relating to novel compounds and targets thereof
|
|
US20030119029A1
(en)
*
|
1999-04-30 |
2003-06-26 |
Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
|
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
EP1143946B1
(en)
*
|
1999-04-30 |
2004-01-28 |
The Regents Of The University Of Michigan |
Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
|
|
US20040176358A1
(en)
*
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20060025388A1
(en)
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20050272723A1
(en)
*
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
US20060052369A1
(en)
*
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US7638624B2
(en)
*
|
2005-01-03 |
2009-12-29 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and derivatives
|
|
US20070043033A1
(en)
|
2005-06-01 |
2007-02-22 |
The Regents Of The University Of Michigan |
Unsolvated benzodiazepine compositions and methods
|
|
US20070105844A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
|
NZ568254A
(en)
|
2005-11-01 |
2011-06-30 |
Univ Michigan |
1,4-Benzodiazepine-2,5-diones for regulating cell death and treating autoimmune diseases
|
|
US7759338B2
(en)
*
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|
|
EP2418206A3
(en)
|
2006-06-09 |
2012-06-27 |
The Regents of the University of Michigan |
Benzodiazepine derivatives useful in the treatment of autoimmune disorders
|
|
MX2009009645A
(es)
|
2007-03-09 |
2009-11-19 |
Univ Michigan |
Composiciones y metodos relacionados con nuevos compuestos y objetivos de los mismos.
|
|
EP2200977B1
(en)
|
2007-09-14 |
2016-11-09 |
The Regents of the University of Michigan |
F1f0-atpase inhibitors and related methods
|
|
WO2009061916A2
(en)
|
2007-11-06 |
2009-05-14 |
The Regents Of The University Of Michigan |
Benzodiazepinone compounds useful in the treatment of skin conditions
|
|
AU2009291632B2
(en)
|
2008-09-11 |
2013-04-04 |
The Regents Of The University Of Michigan |
Aryl guanidine F1F0-ATPase inhibitors and related methods
|
|
WO2010121164A2
(en)
|
2009-04-17 |
2010-10-21 |
The Regents Of The University Of Michigan |
1,4-benzodiazepinone compounds and their use in treating cancer
|
|
EP2470020A4
(en)
|
2009-09-18 |
2013-03-13 |
Univ Michigan |
BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH
|
|
AU2010322287B2
(en)
|
2009-11-17 |
2014-04-03 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|
|
US9126978B2
(en)
|
2009-11-17 |
2015-09-08 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|